Tanacetum parthenium and Salix alba (Mig-RL) Combination in Migraine Prophylaxis

R. Shrivastava; J.C. Pechadre; G.W. John

Disclosures

Clin Drug Invest. 2006;26(5):287-296. 

In This Article

Conclusion

Notwithstanding the study's limitations, the objectives of this open-label, investigational trial were largely attained. The remarkable results obtained with Mig-RL® with respect to attack frequency, pain intensity and attack duration justify a randomised, placebo-controlled study in a larger population of migraineurs, including those with aura. Importantly, the over-the-counter availability of Mig-RL® may help improve the lives of the large numbers of headache sufferers, including the 50% of all migraineurs who have never been diagnosed or who are reluctant to consult their doctor.[3]

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....